EAN 2021: ADVANCE Trial Demonstrates Benefits of Atogepant for Migraine
Improvements in symptoms were observed with doses as low as 10 mg once daily
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Improvements in symptoms were observed with doses as low as 10 mg once daily
Only registered members have full access to PracticeUpdate content.